What is Korro Bio, Inc.?
, a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 167.18M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 15122,980 shares $1.8M | 479,809 shares $885k |
| 3-6months | 14,884 shares $68k | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |